Novel isoindoline compounds are disclosed. Methods of treating, preventing and/or managing cancer, diseases and disorders associated with, or characterized by, undesired angiogenesis, and diseases and disorders mediated by PDE 4, using the compounds are also disclosed.

 
Web www.patentalert.com

< Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

> CD40-Ligand lacking native-pattern glycosylation
~ 00450